Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|November 11, 2005
Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonistsGuo Zhu Zheng, Pramila Bhatia, Jerome Daanen, et al.Bioorganic & Medicinal Chemistry Letters|July 1, 2006
Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonistsGuo Zhu Zheng, Pramila Bhatia, Teodozyj Kolasa, et al.Journal of Medicinal Chemistry|July 9, 2004
Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunctionMarlon Cowart, Steven P Latshaw, Pramila Bhatia, et al.European Journal of Medicinal Chemistry|November 16, 2016
A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivativesSujay Basu, Dinesh A Barawkar, Vidya Ramdas, et al.European Journal of Medicinal Chemistry|April 18, 2017
Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseasesSujay Basu, Dinesh A Barawkar, Vidya Ramdas, et al.ACS Medicinal Chemistry Letters|August 25, 2017
Discovery of Potent and Selective A2A Antagonists with Efficacy in Animal Models of Parkinson's Disease and DepressionSujay Basu, Dinesh A Barawkar, Vidya Ramdas, et al.Journal of Medicinal Chemistry|January 6, 2017
Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A2A Receptor Antagonists and Their Biological EvaluationSujay Basu, Dinesh A Barawkar, Sachin Thorat, et al.Pageof 2